BIO-TECHNE CORP (TECH) Fundamental Analysis & Valuation

NASDAQ:TECH • US09073M1045

Current stock price

60.22 USD
-0.36 (-0.59%)
Last:

This TECH fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. TECH Profitability Analysis

1.1 Basic Checks

  • TECH had positive earnings in the past year.
  • In the past year TECH had a positive cash flow from operations.
  • Each year in the past 5 years TECH has been profitable.
  • In the past 5 years TECH always reported a positive cash flow from operatings.
TECH Yearly Net Income VS EBIT VS OCF VS FCFTECH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

1.2 Ratios

  • TECH has a better Return On Assets (3.17%) than 75.00% of its industry peers.
  • Looking at the Return On Equity, with a value of 3.98%, TECH is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 9.52%, TECH belongs to the top of the industry, outperforming 89.29% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for TECH is below the industry average of 11.80%.
  • The 3 year average ROIC (9.00%) for TECH is below the current ROIC(9.52%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.17%
ROE 3.98%
ROIC 9.52%
ROA(3y)6.63%
ROA(5y)7.59%
ROE(3y)8.82%
ROE(5y)10.28%
ROIC(3y)9%
ROIC(5y)9.64%
TECH Yearly ROA, ROE, ROICTECH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • Looking at the Profit Margin, with a value of 6.58%, TECH is in the better half of the industry, outperforming 69.64% of the companies in the same industry.
  • In the last couple of years the Profit Margin of TECH has declined.
  • The Operating Margin of TECH (22.59%) is better than 92.86% of its industry peers.
  • TECH's Operating Margin has been stable in the last couple of years.
  • The Gross Margin of TECH (66.60%) is better than 87.50% of its industry peers.
  • In the last couple of years the Gross Margin of TECH has remained more or less at the same level.
Industry RankSector Rank
OM 22.59%
PM (TTM) 6.58%
GM 66.6%
OM growth 3Y-6.91%
OM growth 5Y1.3%
PM growth 3Y-37.46%
PM growth 5Y-27.97%
GM growth 3Y-0.95%
GM growth 5Y0.33%
TECH Yearly Profit, Operating, Gross MarginsTECH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

8

2. TECH Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so TECH is destroying value.
  • Compared to 1 year ago, TECH has less shares outstanding
  • TECH has more shares outstanding than it did 5 years ago.
  • TECH has a worse debt/assets ratio than last year.
TECH Yearly Shares OutstandingTECH Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
TECH Yearly Total Debt VS Total AssetsTECH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

2.2 Solvency

  • An Altman-Z score of 12.80 indicates that TECH is not in any danger for bankruptcy at the moment.
  • TECH has a better Altman-Z score (12.80) than 96.43% of its industry peers.
  • The Debt to FCF ratio of TECH is 1.17, which is an excellent value as it means it would take TECH, only 1.17 years of fcf income to pay off all of its debts.
  • TECH has a Debt to FCF ratio of 1.17. This is amongst the best in the industry. TECH outperforms 91.07% of its industry peers.
  • TECH has a Debt/Equity ratio of 0.13. This is a healthy value indicating a solid balance between debt and equity.
  • TECH has a Debt to Equity ratio of 0.13. This is in the better half of the industry: TECH outperforms 62.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF 1.17
Altman-Z 12.8
ROIC/WACC0.86
WACC11.03%
TECH Yearly LT Debt VS Equity VS FCFTECH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.3 Liquidity

  • TECH has a Current Ratio of 4.54. This indicates that TECH is financially healthy and has no problem in meeting its short term obligations.
  • With a decent Current ratio value of 4.54, TECH is doing good in the industry, outperforming 75.00% of the companies in the same industry.
  • A Quick Ratio of 3.08 indicates that TECH has no problem at all paying its short term obligations.
  • TECH has a Quick ratio of 3.08. This is in the better half of the industry: TECH outperforms 62.50% of its industry peers.
Industry RankSector Rank
Current Ratio 4.54
Quick Ratio 3.08
TECH Yearly Current Assets VS Current LiabilitesTECH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

5

3. TECH Growth Analysis

3.1 Past

  • TECH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 8.84%, which is quite good.
  • The Earnings Per Share has been growing by 11.25% on average over the past years. This is quite good.
  • The Revenue has been growing slightly by 1.64% in the past year.
  • TECH shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.55% yearly.
EPS 1Y (TTM)8.84%
EPS 3Y-0.77%
EPS 5Y11.25%
EPS Q2Q%9.52%
Revenue 1Y (TTM)1.64%
Revenue growth 3Y3.33%
Revenue growth 5Y10.55%
Sales Q2Q%0.24%

3.2 Future

  • The Earnings Per Share is expected to grow by 8.61% on average over the next years. This is quite good.
  • Based on estimates for the next years, TECH will show a small growth in Revenue. The Revenue will grow by 7.10% on average per year.
EPS Next Y4.8%
EPS Next 2Y7.28%
EPS Next 3Y9.92%
EPS Next 5Y8.61%
Revenue Next Year0.73%
Revenue Next 2Y3.52%
Revenue Next 3Y5.57%
Revenue Next 5Y7.1%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
TECH Yearly Revenue VS EstimatesTECH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 500M 1B 1.5B 2B
TECH Yearly EPS VS EstimatesTECH Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.5 1 1.5 2 2.5

4

4. TECH Valuation Analysis

4.1 Price/Earnings Ratio

  • TECH is valuated quite expensively with a Price/Earnings ratio of 30.57.
  • Based on the Price/Earnings ratio, TECH is valued a bit cheaper than the industry average as 69.64% of the companies are valued more expensively.
  • TECH's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.95.
  • A Price/Forward Earnings ratio of 27.11 indicates a quite expensive valuation of TECH.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of TECH indicates a somewhat cheap valuation: TECH is cheaper than 71.43% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 38.68, TECH is valued a bit cheaper.
Industry RankSector Rank
PE 30.57
Fwd PE 27.11
TECH Price Earnings VS Forward Price EarningsTECH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • TECH's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. TECH is cheaper than 62.50% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, TECH is valued a bit cheaper than the industry average as 62.50% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 42.24
EV/EBITDA 25.28
TECH Per share dataTECH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates TECH does not grow enough to justify the current Price/Earnings ratio.
  • TECH has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)6.37
PEG (5Y)2.72
EPS Next 2Y7.28%
EPS Next 3Y9.92%

4

5. TECH Dividend Analysis

5.1 Amount

  • With a yearly dividend of 0.56%, TECH is not a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 0.11, TECH pays a better dividend. On top of this TECH pays more dividend than 92.86% of the companies listed in the same industry.
  • With a Dividend Yield of 0.56, TECH pays less dividend than the S&P500 average, which is at 1.81.
Industry RankSector Rank
Dividend Yield 0.56%

5.2 History

  • The dividend of TECH has a limited annual growth rate of 0.11%.
  • TECH has been paying a dividend for at least 10 years, so it has a reliable track record.
  • TECH has decreased its dividend in the last 3 years.
Dividend Growth(5Y)0.11%
Div Incr Years0
Div Non Decr Years2
TECH Yearly Dividends per shareTECH Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0 0 0 0

5.3 Sustainability

  • 62.38% of the earnings are spent on dividend by TECH. This is not a sustainable payout ratio.
  • TECH's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP62.38%
EPS Next 2Y7.28%
EPS Next 3Y9.92%
TECH Yearly Income VS Free CF VS DividendTECH Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
TECH Dividend Payout.TECH Dividend Payout, showing the Payout Ratio.TECH Dividend Payout.PayoutRetained Earnings

TECH Fundamentals: All Metrics, Ratios and Statistics

BIO-TECHNE CORP

NASDAQ:TECH (4/21/2026, 11:52:18 AM)

60.22

-0.36 (-0.59%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)02-04
Earnings (Next)05-06
Inst Owners113.81%
Inst Owner Change-0.28%
Ins Owners0.26%
Ins Owner Change1.89%
Market Cap9.42B
Revenue(TTM)1.22B
Net Income(TTM)79.96M
Analysts80.87
Price Target76.73 (27.42%)
Short Float %9.04%
Short Ratio5.87
Dividend
Industry RankSector Rank
Dividend Yield 0.56%
Yearly Dividend0.32
Dividend Growth(5Y)0.11%
DP62.38%
Div Incr Years0
Div Non Decr Years2
Ex-Date02-13
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.96%
Min EPS beat(2)-2.04%
Max EPS beat(2)3.95%
EPS beat(4)3
Avg EPS beat(4)3.35%
Min EPS beat(4)-2.04%
Max EPS beat(4)7.36%
EPS beat(8)6
Avg EPS beat(8)3.61%
EPS beat(12)6
Avg EPS beat(12)1.11%
EPS beat(16)7
Avg EPS beat(16)-2.33%
Revenue beat(2)0
Avg Revenue beat(2)-1.79%
Min Revenue beat(2)-3.53%
Max Revenue beat(2)-0.04%
Revenue beat(4)0
Avg Revenue beat(4)-1.87%
Min Revenue beat(4)-3.53%
Max Revenue beat(4)-0.04%
Revenue beat(8)3
Avg Revenue beat(8)-0.65%
Revenue beat(12)3
Avg Revenue beat(12)-1.76%
Revenue beat(16)4
Avg Revenue beat(16)-2.17%
PT rev (1m)0%
PT rev (3m)7.39%
EPS NQ rev (1m)-0.04%
EPS NQ rev (3m)-4.68%
EPS NY rev (1m)-0.23%
EPS NY rev (3m)0.14%
Revenue NQ rev (1m)0.11%
Revenue NQ rev (3m)-1.33%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.16%
Valuation
Industry RankSector Rank
PE 30.57
Fwd PE 27.11
P/S 7.75
P/FCF 42.24
P/OCF 37.79
P/B 4.68
P/tB 13.55
EV/EBITDA 25.28
EPS(TTM)1.97
EY3.27%
EPS(NY)2.22
Fwd EY3.69%
FCF(TTM)1.43
FCFY2.37%
OCF(TTM)1.59
OCFY2.65%
SpS7.77
BVpS12.85
TBVpS4.45
PEG (NY)6.37
PEG (5Y)2.72
Graham Number23.8694 (-60.36%)
Profitability
Industry RankSector Rank
ROA 3.17%
ROE 3.98%
ROCE 11.53%
ROIC 9.52%
ROICexc 10.26%
ROICexgc 25.36%
OM 22.59%
PM (TTM) 6.58%
GM 66.6%
FCFM 18.35%
ROA(3y)6.63%
ROA(5y)7.59%
ROE(3y)8.82%
ROE(5y)10.28%
ROIC(3y)9%
ROIC(5y)9.64%
ROICexc(3y)9.68%
ROICexc(5y)10.59%
ROICexgc(3y)24.93%
ROICexgc(5y)34.08%
ROCE(3y)10.9%
ROCE(5y)11.68%
ROICexgc growth 3Y-19.18%
ROICexgc growth 5Y-3.96%
ROICexc growth 3Y-9.13%
ROICexc growth 5Y5.53%
OM growth 3Y-6.91%
OM growth 5Y1.3%
PM growth 3Y-37.46%
PM growth 5Y-27.97%
GM growth 3Y-0.95%
GM growth 5Y0.33%
F-Score8
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF 1.17
Debt/EBITDA 0.69
Cap/Depr 25.35%
Cap/Sales 2.16%
Interest Coverage 15.32
Cash Conversion 65.89%
Profit Quality 278.92%
Current Ratio 4.54
Quick Ratio 3.08
Altman-Z 12.8
F-Score8
WACC11.03%
ROIC/WACC0.86
Cap/Depr(3y)40.04%
Cap/Depr(5y)43.01%
Cap/Sales(3y)3.78%
Cap/Sales(5y)4.03%
Profit Quality(3y)188.66%
Profit Quality(5y)177.71%
High Growth Momentum
Growth
EPS 1Y (TTM)8.84%
EPS 3Y-0.77%
EPS 5Y11.25%
EPS Q2Q%9.52%
EPS Next Y4.8%
EPS Next 2Y7.28%
EPS Next 3Y9.92%
EPS Next 5Y8.61%
Revenue 1Y (TTM)1.64%
Revenue growth 3Y3.33%
Revenue growth 5Y10.55%
Sales Q2Q%0.24%
Revenue Next Year0.73%
Revenue Next 2Y3.52%
Revenue Next 3Y5.57%
Revenue Next 5Y7.1%
EBIT growth 1Y9.53%
EBIT growth 3Y-3.81%
EBIT growth 5Y11.98%
EBIT Next Year16.58%
EBIT Next 3Y12.12%
EBIT Next 5Y8.56%
FCF growth 1Y-1.07%
FCF growth 3Y-2.92%
FCF growth 5Y10.82%
OCF growth 1Y-9.8%
OCF growth 3Y-4.03%
OCF growth 5Y6.98%

BIO-TECHNE CORP / TECH Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for BIO-TECHNE CORP?

ChartMill assigns a fundamental rating of 6 / 10 to TECH.


What is the valuation status of BIO-TECHNE CORP (TECH) stock?

ChartMill assigns a valuation rating of 4 / 10 to BIO-TECHNE CORP (TECH). This can be considered as Fairly Valued.


Can you provide the profitability details for BIO-TECHNE CORP?

BIO-TECHNE CORP (TECH) has a profitability rating of 7 / 10.


Can you provide the financial health for TECH stock?

The financial health rating of BIO-TECHNE CORP (TECH) is 8 / 10.


What is the expected EPS growth for BIO-TECHNE CORP (TECH) stock?

The Earnings per Share (EPS) of BIO-TECHNE CORP (TECH) is expected to grow by 4.8% in the next year.